Objectives This study aims to measure the effect of Construction of Healthcare Consortium (CHC) on the allocation and equity of human resources (HR) for primary health care (PHC) in China, at the same time, it provides some data to support the government's policies improvement in the next stage. Methods: Changes in the equity of allocation of HR for PHC by population are demonstrated through a three-stage approach to inequality analysis that includes the Gini coefficient (G), the Theil index (T), the concentration index (CI) and concentration curve. The GM(1,1) model is used to project the trend of resources from 2021 to 2030. Results: Volume of HR for PHC accelerates at an average rate of growth following the release of CHC in the 2016. whilst some regions have seen their G and T rise between 2012 and 2016, their levels of inequality of allocation for resource shave gradually declined in the years following 2016, but there are exceptions, with the regions of northeast and northwest seeing the opposite. Eastern and northern region account for a larger contribution to intra-regional inequality. Concentration indices and concentration curves indicate that HR for PHC is related to economic income levels. GM (1, 1) projects an increasing trend in resources from 2021 to 2030, but with variations in average growth rates in different regions. Conclusions: The inequality of human resources for primary health care in China is low, however, the inequality between regions has not been eliminated. We still need to take a long-term view to monitor the impact of CHC on the allocation of HR for PHC and its equity in China.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data for this study come from publicly available yearbooks of the National Statistical Office.This study did not involve the human participants.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

within the manuscript and/or Supporting Information files